Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,141
Total Claims
$1.2M
Drug Cost
610
Beneficiaries
$1,905
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+55%
Opioid rate vs peers
4.0% vs 2.6% avg
+78%
Cost per patient vs peers
$1,905 vs $1,068 avg
+42%
Brand preference vs peers
12.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.0%
Opioid Rate
444
Opioid Claims
$8,062
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,406 claims · $1.0M
Generic: 9,583 claims · $131K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 76 | $91K |
| Semaglutide | 50 | $78K |
| Fluticasone/Umeclidin/Vilanter | 72 | $78K |
| Dulaglutide | 48 | $77K |
| Insulin Glargine,hum.Rec.Anlog | 101 | $72K |
| Empagliflozin | 43 | $59K |
| Sitagliptin Phosphate | 49 | $56K |
| Budesonide/Formoterol Fumarate | 52 | $53K |
| Tiotropium Bromide | 44 | $53K |
| Fluticasone/Vilanterol | 51 | $35K |
| Tiotropium Br/Olodaterol Hcl | 39 | $34K |
| Mirabegron | 42 | $28K |
| Liraglutide | 12 | $27K |
| Linaclotide | 17 | $23K |
| Rivaroxaban | 18 | $22K |
Prescribing Profile
Patient Profile
68
Avg Age
57%
Female
2.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About